claim: favipiravir strikes the sars-cov-2 at its end heel, the rna polymerase
evidence_1: here we show that favipiravir exerts an antiviral effect as a nucleotide analogue through a combination of chain termination, slowed rna synthesis and lethal mutagenesis.